Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in National Health Investors Inc (NYSE:NHI) by 9.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 18,267 shares of the real estate investment trust’s stock after purchasing an additional 1,622 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in National Health Investors were worth $905,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Goldman Sachs Group Inc. boosted its stake in shares of National Health Investors by 1.3% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,025,218 shares of the real estate investment trust’s stock worth $83,534,000 after acquiring an additional 13,079 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of National Health Investors by 13.5% during the 1st quarter. Bank of New York Mellon Corp now owns 900,976 shares of the real estate investment trust’s stock worth $44,617,000 after acquiring an additional 107,216 shares in the last quarter. Bank of America Corp DE boosted its stake in shares of National Health Investors by 3.2% during the 4th quarter. Bank of America Corp DE now owns 678,762 shares of the real estate investment trust’s stock worth $55,305,000 after acquiring an additional 20,905 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of National Health Investors by 9.5% during the 4th quarter. Geode Capital Management LLC now owns 610,121 shares of the real estate investment trust’s stock worth $49,712,000 after acquiring an additional 53,107 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of National Health Investors during the 4th quarter worth about $43,207,000. 70.53% of the stock is currently owned by institutional investors.

Several research firms have recently issued reports on NHI. Berenberg Bank began coverage on shares of National Health Investors in a research note on Wednesday, February 5th. They set a “buy” rating and a $94.00 target price on the stock. Wells Fargo & Co lowered their target price on shares of National Health Investors from $82.00 to $51.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 26th. ValuEngine lowered shares of National Health Investors from a “hold” rating to a “sell” rating in a research note on Thursday, April 2nd. KeyCorp reduced their price target on shares of National Health Investors from $43.00 to $40.00 and set an “underweight” rating for the company in a research report on Thursday, May 14th. Finally, Mizuho downgraded shares of National Health Investors from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $60.00 to $55.00 in a research report on Friday. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $67.57.

NHI opened at $52.98 on Friday. National Health Investors Inc has a twelve month low of $31.37 and a twelve month high of $91.12. The company has a quick ratio of 12.05, a current ratio of 12.05 and a debt-to-equity ratio of 1.03. The company has a 50-day moving average price of $50.81 and a 200 day moving average price of $71.49. The company has a market cap of $2.41 billion, a PE ratio of 9.71 and a beta of 0.85.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Monday, May 11th. The real estate investment trust reported $1.37 earnings per share for the quarter, missing the consensus estimate of $1.40 by ($0.03). The company had revenue of $83.08 million for the quarter, compared to analyst estimates of $80.77 million. National Health Investors had a return on equity of 12.62% and a net margin of 57.16%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the company earned $1.31 EPS. As a group, sell-side analysts expect that National Health Investors Inc will post 5.59 earnings per share for the current year.

In other National Health Investors news, CEO D. Eric Mendelsohn sold 4,000 shares of the stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $90.58, for a total value of $362,320.00. Following the completion of the sale, the chief executive officer now owns 44,256 shares in the company, valued at approximately $4,008,708.48. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director W Andrew Adams acquired 27,000 shares of the business’s stock in a transaction on Monday, March 23rd. The stock was acquired at an average price of $36.16 per share, with a total value of $976,320.00. Following the acquisition, the director now owns 759,784 shares in the company, valued at approximately $27,473,789.44. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 29,576 shares of company stock valued at $1,096,421. 5.74% of the stock is owned by insiders.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: Do stock splits help investors?

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.